Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Keith O’Brien
miR-134 in Extracellular Vesicles Reduces Triple-Negative Breast Cancer Aggression and Increases Drug Sensitivity
Oncotarget
Oncology
Synthesis of Orthogonally Protected Azalanthionines (Lanazanines) by Sequential Ring-Opening of N-Substituted Aziridine 2-Carboxylates
Tetrahedron Letters
Organic Chemistry
Biochemistry
Drug Discovery
Related publications
miR-200–containing Extracellular Vesicles Promote Breast Cancer Cell Metastasis
Journal of Clinical Investigation
Medicine
Triple-Negative Breast Cancer
ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells
International Journal of Molecular Medicine
Medicine
Genetics
Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
DNA Methyltransferase Expression in Triple-Negative Breast Cancer Predicts Sensitivity to Decitabine
Journal of Clinical Investigation
Medicine
Curcumin Restores Sensitivity to Retinoic Acid in Triple Negative Breast Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
MiR-34b Is Associated With Clinical Outcome in Triple-Negative Breast Cancer Patients
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology